Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Fatima J. Jawad"'
Autor:
Zahraa M. Al-Sharify, Fatima J. Jawad
Publikováno v:
مجلة كلية الطب, Vol 66, Iss 3 (2024)
Background: Oral anticoagulation medication, warfarin, and non-vitamin K antagonist oral anticoagulants (NOAC) may require long-term use which may affect patients’ satisfaction with their treatment and their quality of life (QOL). Objective: To c
Externí odkaz:
https://doaj.org/article/21770486d9554f4c863d18d794fa0f7f
Autor:
Mustapha M. AlKhalidi, Fatima J. Jawad
Publikováno v:
Iraqi Journal of Pharmaceutical Sciences, Vol 29, Iss 1, Pp 76-87 (2020)
Etoricoxib (EXB) is a highly selective cox-2 inhibitor which belongs to the non-steroidal anti-inflammatory drug (NSAID). EXB is a class II drug according to the biopharmaceutical classification system (BCS), which possess a very low aqueous solubili
Externí odkaz:
https://doaj.org/article/ccbbe9a123694db59de9b35b9ac16101
Publikováno v:
Iraqi Journal of Pharmaceutical Sciences, Vol 16, Iss 1 (2017)
Anise and thyme crude extract were used to prepare a lotion for topical application due to their antimicrobial, germicidal and antifungal effects. Two formulas were prepared using the mentioned natural plants, formula 2 (selected lotion) was the most
Externí odkaz:
https://doaj.org/article/0644cf7a2264410d938a4c3bca34d307
Autor:
Fatima J. Jawad
Publikováno v:
Iraqi Journal of Pharmaceutical Sciences, Vol 17, Iss 2 (2017)
The present study aim at preparing frusemide in liquid form suitable for oral use. This is achieved through preparing different liquid forms of frusemide. The frusemide liquid is prepared in the following forms: oral solution, syrup and elixir with i
Externí odkaz:
https://doaj.org/article/0f1a5940933f4092aedd63d0ddcf86b1
Autor:
Fatima J. Jawad, Mustapha M. AlKhalidi
Publikováno v:
Iraqi Journal of Pharmaceutical Sciences, Vol 29, Iss 1, Pp 76-87 (2020)
Etoricoxib (EXB) is a highly selective cox-2 inhibitor which belongs to the non-steroidal anti-inflammatory drug (NSAID). EXB is a class II drug according to the biopharmaceutical classification system (BCS), which possess a very low aqueous solubili
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a7e91492b09a699c46d3c53c38fff85
https://doi.org/10.31351/vol29iss1pp76-87
https://doi.org/10.31351/vol29iss1pp76-87